Shunt (CNS) infection: (VA / VP shunt); EVD (external ventricular drain) or lumbar drain (LD)
CNS shunt infection (VA/VP, EVD or LD associated)
- Cerebrospinal fluid should be sent for microscopy and culture.
- Modify treatment according to sensitivity test results.
- Treatment duration is pathogen dependent. Consult Microbiology/ID.
- Detailed guidance for the management of infected CSF shunts is found here: Management of infected neurosurgical shunts (VP and EVD)
Preferred
ceftazidime 2g iv tds (if patient is over 80 years of age the usual daily maximum dose of ceftazidime is 3g; this can be increased to 6g daily on advice documented by ID Micro Consultant)
AND
linezolid 600mg po (iv if NBM) bd (See linezolid drug monograph for information about monitoring required)
If unable to have linezolid: substitute linezolid with vancomycin iv
Alternative
For penicillin allergy (severe)
ciprofloxacin* 400mg iv bd (500mg po bd). Ciprofloxacin may induce seizures in patients with or without a history of seizures – use with caution
AND
linezolid 600mg po (iv if NBM) bd (See linezolid drug monograph for information about monitoring required)
If unable to have linezolid: substitute linezolid with vancomycin iv
*Ensure that the patient is given the Fluoroquinolone MHRA patient information leaflet.
Fluoroquinolones, including ciprofloxacin, are associated with disabling and potentially long-lasting or irreversible side effects. See Fluoroquinolone antibiotics - severe adverse effects.
Salvage (where device removal is not feasible)
ceftazidime 2g iv tds (Note: if patient is over 80 years of age the usual daily maximum dose of ceftazidime is 3g; this can be increased to 6g daily on advice documented by ID Micro Consultant)
AND
linezolid 600mg po (iv if NBM) bd (See linezolid drug monograph for information about monitoring required)
If unable to have linezolid: substitute linezolid with vancomycin iv
Consider adding: vancomycin 10 mg od intrathecally administered
Recommended antimicrobial treatment once pathogen known
Choices should be guided by susceptibility results and after discussion with Adult or Paeds ID team
Microorganism |
Preferred |
Alternative therapies |
Staphylococci methicillin-sensitive methicillin-resistant |
|
vancomycin, ceftaroline, co-trimoxazole |
Cutibacterium acnes |
||
Pseudomonas aeruginosa |
|
meropenem, aztreonam, ciprofloxacin, colistimethate sodium, Ceftolozane with tazobactam, fosfomycin IV |
ESBL enterobacteriaceae |
||
Other enterobacteriaceae |
||
Candida spp |
For dosing - always discuss with Micro/ID